Back to results
US 12,612,414 B2Granted
Nitrile SUMO inhibitors and uses thereof
AssigneeCit Therapeutics, Inc.
InventorsMiles Douglas Kubota, Andrew S. Tasker, Fang-Tsao Hong, Mary Walton, Victor J. Cee, Peter Buchowiecki
Life of this patent
Estimating the term…
Abstract
The present invention relates to cyano-containing compounds and compositions capable of acting as inhibitors of small ubiquitin-like modifier (SUMO) family of proteins. The compounds and compositions may be used in the treatment of cancer. There are disclosed, inter alia, methods of inhibiting an E1 enzyme, and compounds useful for inhibiting an E1 enzyme.
Claims18
A compound of the structure of Formula IV or Formula V:
- wherein
- R1 is substituted or unsubstituted C2-C6 alkenyl, or substituted or unsubstituted C2-C6 alkynyl;
- R6 is selected from H, C1-6 alkyl, C2-4 alkynyl, C1-6 hydroxyalkyl, C1-6 alkoxyalkyl, C1-6 alkylamino-C1-6 alkyl, C1-6 alkylaminocarbonyl-C1-6 alkyl, aminocarbonyl-C1-6 alkyl, C1-6 alkoxycarbonyl-C1-6 alkyl, carboxy-C1-6 alkyl, C1-6 alkylcarbonylamino-C1-6 alkyl, C1-6 cyanoalkyl, C1-6 haloalkyl, C1-6 alkylsulfonyl, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-6 alkyl, aryl-C1-6 alkyl, substituted or unsubstituted 5 or 6 membered heteroaryl-C1-6 alkyl, substituted or unsubstituted 5 or 6 membered heterocyclyl and substituted or unsubstituted 5 or 6 membered heteroaryl;
- R7 is selected from H, carboxy, amino, C1-6 alkyl, C1-3 haloalkyl, C1-6 alkoxy, C1-6 alkylamino, C1-6 alkylaminocarbonyl, and C3-6 cycloalkyl;
- R8 is selected from H, carboxy, cyano, C1-4 alkyl, C1-3 haloalkyl, and C1-6 alkylaminocarbonyl;
- R9 is selected from H, halo, hydroxy, C1-3 alkyl, C1-3 haloalkyl, cyano, amino, C1-3 alkylcarbonylamino, C1-3 alkylsulfonylamino, and C1-3 alkylaminocarbonylamino;
- R10 is selected from H, halo, hydroxy, C1-3 alkyl, C1-3 haloalkyl, cyano, amino, C1-3 alkylcarbonylamino, C1-3 alkylsulfonylamino, and C1-3 alkylaminocarbonylamino;
- and
- R11 is selected from H, halo, hydroxy, C1-3 alkyl, C1-3 haloalkyl, cyano, amino, C1-3 alkylcarbonylamino, C1-3 alkylsulfonylamino, and C1-3 alkylaminocarbonylamino;
- or a pharmaceutically acceptable salt thereof.
7 more elements
A compound having a structure selected from
Dependencies are inferred from the claim text.